Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Opal acquisition of Formulytica – Capital raising

Opal acquisition of Formulytica – Capital raising May 6, 2021 • Category • Author Name

Opal acquisition of Formulytica – Capital raising

Latest News

Results of General Meeting and 2016 CPS Meeting

September 9, 2024

240909_BDM_AGM_ResultsofMeeting_Shareholders_Final

Read More
BioDiem Notice of General Meeting and Proxy Form

August 16, 2024

BioDiem Notice of General Meeting and Proxy Form

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions